Did a grown man/woman that has never done a FDA trial write this?
There's one team bickering and that's Cynata. The other team, Mesoblast, has never mentioned Cynata.
Look within.
You're only not liking it now because it's backfired and your team is being exposed.
The truth of the matter is CYP needs MSB to succeed and the sooner the better. MSB doesn't have the time required to wait for CYP as they are so far away.
It's a shark (Mesoblast) and a parasite fish (Cynata).
I'm watching because I'm interested in investing. So far, not investing here has been a stellar decision. I will read the next announcement and think about it.
What I am doing is called investing.
CYP Price at posting:
26.5¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)